| 영문 | rheumatoid factor | 한글 | 류마티스 인자 |
|---|---|---|---|
| 설명 | IgG의 Fc부위에 있는 항원결정인자에 대한 항체로서 전형적인 또는 확실한 류마티스관절염(rheumatoid arthritis) 환자의 80%에서 발견된다. 류마티스 인자는 IgM, IgG, IgA중 하나가 될 수 있으나 주로 IgM이다. 소아류마티스관절염(juvenile rheumatoid arthritis: 소아기에 발생하는 류마티스관절염)을 비롯한, 다른 결합조직병이나 감염병에도 나타날 수 있다 |
||
| 영문 | growth factor | 한글 | 성장인자 |
|---|---|---|---|
| 설명 | 세포의 분화 및 성장에 관여하는 단백질. 성장인자는 정상 세포주기에 필수적이기 때문에 동물의 생명에 중대한 요소가 된다. 무엇보다도 성장인자는 태아의 발육을 조정하고 조직의 유지 및 보수에 중대한 역할을 하며, 혈구의 생성을 자극한다. 또한 암의 진행과정에도 관여한다. |
||
| 영문 | risk factor | 한글 | 위험인자 |
|---|---|---|---|
| 설명 | 국제방사선방호위원회(ICRP)가 1977년 권고에서 방사선방호의 목적으로 채택한 지수로, 단위선량(1 Sv)당 확률적 영향의 발생확률을 추정하여 나타낸 것이다. 생식선 선량에 대한 유전적영향의 발생률(4×10－3/Sv)이나 적색골수선량에 대한 백혈병 발생률(2×10－3/Sv)등 외에 뼈, 허파, 갑상샘, 젖샘, 기타 조직의 위험지수를 측정하여, 확률적 영향의 전신에 있어서 치사위험지수의 합계를 16.5×10－3/Sv로 하였다. 그후 ICRP는 1990년 권고에서 대상이 되는 조직과 장기를 추가하고, 수치 개정을 하면서 명칭도 각목적확률지수라고하였다. 이 권고에 의하면, 치사적 확률적 영향의 확률지수의 합계는, 일반인에 있어 60.0×10－3/Sv이다. |
||
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
|---|---|
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| SF | Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f... |
| E.A.A. | Extrinsic Allergic Alveolitis |
|---|---|
| EPI | Extrinsic Pathway Inhibitor |
| D factor | Differentiation-stimulating factor |
| TRAF | Factor Receptor-associated factor |
| FVIII-vWF | Factor VIII-von Willebrand Factor |
IGF-II : insulin like growth factor-II의 약자. 많은 장기와 조직에 작용하여 단백 합성과 DNA, RNA의 합성을 증가시켜 세포의 수와 양을 증가
| extrinsic factor | Dietary vitamin B12. (05 Mar 2000) |
|---|---|
| extrinsic factor deficiency | <disease> An inherited disorder that causes abnormal blood clotting due to the congenital absence of one of the 20 different plasma proteins involved in the coagulation process. Symptoms include bleeding of the gums, nosebleeds, easy bruising, bleeding in muscles or joints and excessive menstrual bleeding. Treatment includes the administration of plasma concentrates of factor VII (extrinsic factor). (27 Sep 1997) |
| acute extrinsic allergic alveolitis | <radiology> No chest X-ray findings in 30-95%, diffuse acinar consolidative pattern (oedema and exudative filling of alveoli), basilar distribution, lymph node enlargement (unusual, more common with recurrence) see: extrinsic allergic alveolitis (12 Dec 1998) |
|---|---|
| alveolitis, extrinsic allergic | Conditions in which inhalation of organic dusts results in hypersensitivity reactions at the alveolar level, associated with the production of precipitins. (12 Dec 1998) |
| extrinsic | 1. Not contained in or belonging to a body; external; outward; unessential; opposed to intrinsic. "The extrinsic aids of education and of artificial culture." (I. Taylor) 2. <anatomy> Attached partly to an organ or limb and partly to some other part said of certain groups of muscles. Opposed to intrinsic. Origin: L. Extrinsecus; exter on the outside + secus otherwise, beside; akin to E. Second: cf. F. Extrinseque. See Exterior, Second. Source: Websters Dictionary (01 Mar 1998) |
| extrinsic allergic alveolitis | <radiology> Exposure to organic dust less than 5u in size, recurrent episodes of fever, chills, dry cough, dyspnea following exposure after 6 hr interval (10-40% assymptomatic), spontaneous resolution in 1-2 days, farmer's lung, Pandora's pneumonitis, bird-fancier's lung, mushroom worker's lung, bagassosis, malt worker's lung, maple bark disease, suberosis, sequoiosis see: acute extrinsic allergic alveolitis, hypersensitivity pneumonitis (12 Dec 1998) |
| extrinsic asthma | Bronchial asthma resulting from an allergic reaction to foreign substances, such as inhaled particles, vapors, or gases, or ingested foods, beverages, or drugs. (05 Mar 2000) |
| extrinsic colour | Colour applied to the external surface of a dental prosthesis. (05 Mar 2000) |
| extrinsic incubation period | Time required for the development of a disease agent in a vector, from the time of uptake of the agent to the time when the vector is infective. (05 Mar 2000) |
| extrinsic motivation | The search for satisfaction, or to avoid dissatisfaction, through non-task aspects of the environment such as seeking comfort, safety, and security from others or through the efforts of others. (05 Mar 2000) |
| extrinsic muscles | Muscles arising outside of, but which act upon, the structure under consideration. For example, the muscles operating the hand but having fleshy bellies located in the forearm. (05 Mar 2000) |
| extrinsic pathway | <haematology> Initiation of blood clotting as a result of factors released from damaged tissue, as opposed to contact with a foreign surface (the intrinsic pathway). Tissue thromboplastin (Factor III) in conjunction with Factor VII proconvertin) will activate Factor X that, once activated, converts prothrombin to thrombin. (27 Jun 1999) |
| extrinsic protein | <protein> A protein found in a cell or tissue which came from somewhere else (other than the cell or tissue in which it is found). (09 Oct 1997) |
| extrinsic proteins | Pathways that can be easily removed from a biomembrane (e.g., by altering the pH or the ionic strength). Synonym: extrinsic proteins. (05 Mar 2000) |
| extrinsic sphincter | A sphincter provided by circular muscular fibres extraneous to the organ. (05 Mar 2000) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|